Daklinza
- Licence status
- Withdrawn: 30/08/2019
- Active substances
- Daclatasvir dihydrochloride
- Dosage Form
- Film-coated tablet
- Licence number
- EU/1/14/939/003-004
- Licence holder
- Bristol-Myers Squibb Pharma EEIG
Licence information
- ATC code
- J05AX Other antivirals, J05AX14 Other antivirals
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 22/08/2014